1. Home
  2. QRTEA vs NKTX Comparison

QRTEA vs NKTX Comparison

Compare QRTEA & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QRTEA
  • NKTX
  • Stock Information
  • Founded
  • QRTEA 1991
  • NKTX 2015
  • Country
  • QRTEA United States
  • NKTX United States
  • Employees
  • QRTEA N/A
  • NKTX N/A
  • Industry
  • QRTEA Catalog/Specialty Distribution
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • QRTEA Consumer Discretionary
  • NKTX Health Care
  • Exchange
  • QRTEA Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • QRTEA 165.8M
  • NKTX 170.8M
  • IPO Year
  • QRTEA N/A
  • NKTX 2020
  • Fundamental
  • Price
  • QRTEA $0.36
  • NKTX $2.44
  • Analyst Decision
  • QRTEA
  • NKTX Strong Buy
  • Analyst Count
  • QRTEA 0
  • NKTX 5
  • Target Price
  • QRTEA N/A
  • NKTX $15.20
  • AVG Volume (30 Days)
  • QRTEA 2.2M
  • NKTX 1.5M
  • Earning Date
  • QRTEA 02-26-2025
  • NKTX 03-20-2025
  • Dividend Yield
  • QRTEA N/A
  • NKTX N/A
  • EPS Growth
  • QRTEA N/A
  • NKTX N/A
  • EPS
  • QRTEA N/A
  • NKTX N/A
  • Revenue
  • QRTEA $10,236,000,000.00
  • NKTX N/A
  • Revenue This Year
  • QRTEA N/A
  • NKTX N/A
  • Revenue Next Year
  • QRTEA N/A
  • NKTX N/A
  • P/E Ratio
  • QRTEA N/A
  • NKTX N/A
  • Revenue Growth
  • QRTEA N/A
  • NKTX N/A
  • 52 Week Low
  • QRTEA $0.31
  • NKTX $2.08
  • 52 Week High
  • QRTEA $1.80
  • NKTX $16.24
  • Technical
  • Relative Strength Index (RSI)
  • QRTEA 47.82
  • NKTX 49.10
  • Support Level
  • QRTEA $0.32
  • NKTX $2.19
  • Resistance Level
  • QRTEA $0.36
  • NKTX $2.70
  • Average True Range (ATR)
  • QRTEA 0.03
  • NKTX 0.15
  • MACD
  • QRTEA 0.00
  • NKTX 0.03
  • Stochastic Oscillator
  • QRTEA 36.00
  • NKTX 49.02

About QRTEA Qurate Retail Inc. Series A

Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, using their televised shopping programs and via the Internet through their websites and mobile applications; QVC International segment markets and sells a wide variety of consumer products in several foreign countries, using its televised shopping programs and via the Internet through its international websites and mobile applications; and Zulily markets and sells a wide variety of consumer products in the United States and several foreign countries. Geographically, the company operates in U.S, which generates key revenue, Japan, Germany and other regions.

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

Share on Social Networks: